{"id":391134,"date":"2016-05-18T00:00:00","date_gmt":"2016-05-18T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/nrlfon0003-2016-biopharma-hodgkins-lymphoma-niche-rare-disease-landscape-forecast-us-eu5-2016\/"},"modified":"2026-03-31T09:02:11","modified_gmt":"2026-03-31T09:02:11","slug":"nrlfon0003-2016-biopharma-hodgkins-lymphoma-niche-rare-disease-landscape-forecast-us-eu5-2016","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/nrlfon0003-2016-biopharma-hodgkins-lymphoma-niche-rare-disease-landscape-forecast-us-eu5-2016\/","title":{"rendered":"Hodgkin&#8217;s Lymphoma | Niche &#038; Rare Disease Landscape &#038; Forecast | US\/EU5 | 2016"},"content":{"rendered":"<p>The Hodgkin&#8217;s Lymphoma therapy market\u2014currently dominated by multidrug chemotherapy regimens\u2014will experience significant growth over the 2015-2025 forecast. This growth will be fueled by the label expansion of Adcetris and the approval of two immune checkpoint inhibitors, Opdivo (nivolumab) and Keytruda (pembrolizumab).<\/p>\n<p>CONTENT OVERVIEW<\/p>\n<p>From disease basics to insightful analysis of market dynamics, Hodgkin\u2019s lymphoma | Disease Landscape &#038; Forecast | US and EU5 provides comprehensive disease coverage addressing critical aspects of the Hodgkin\u2019s lymphoma pharmaceutical market based on primary and secondary market research. Content pillars include a summary of disease etiology, pathophysiology, and drug targets; annualized epidemiological projections, including estimates of diagnosis and\/or drug-treatment; a deep examination of current therapies and medical practice; a review of top unmet needs; a thorough pipeline assessment, including launch timing, positioning, and peak sales of key late-phase drugs; a topline review of pertinent market access themes; and an epidemiology-based, bottom-up market forecast with supporting tables, figures, and methods.<\/p>\n<p>WHAT YOU WILL LEARN IN THIS CONTENT<\/p>\n<ul>\n<li>How large is the drug-treatable Hodgkin\u2019s lymphoma population and how will drug-treatment rates change over time?<\/li>\n<li>What is the current state of treatment in Hodgkin\u2019s lymphoma? Which are the most important drugs and why? What are interviewed experts\u2019 insights on current treatment options? What clinical needs remain unfulfilled?<\/li>\n<li>What pipeline products are most promising, and what sales\/uptake could they secure in Hodgkin\u2019s lymphoma? What therapies of note are progressing in earlier phases?<\/li>\n<li>What are the drivers and constraints in the Hodgkin\u2019s lymphoma market, and how will the market evolve over the forecast period?<\/li>\n<\/ul>\n<p>KEY DRUGS COVERED<\/p>\n<p>Adcetris, Opdivo, Keytruda, Farydak, Rituxan\/MabThera<\/p>\n<p>KEY COMPANIES MENTIONED<\/p>\n<ul>\n<li>Seattle Genetics<\/li>\n<li>Takeda<\/li>\n<li>Bristol-Myers Squibb<\/li>\n<li>Merck &#038; Co.<\/li>\n<li>Novartis<\/li>\n<li>Roche\/Genentech<\/li>\n<\/ul>\n","protected":false},"template":"","class_list":["post-391134","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-hodgkins-lymphoma","biopharma-therapy-areas-oncology","biopharma-geography-us","biopharma-date-858"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391134\/revisions"}],"predecessor-version":[{"id":576890,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391134\/revisions\/576890"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=391134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}